| Patient | Robert Falcon Scott |
|---|---|
| Date of birth | 1984-06-06 |
| Identifiers | MRN HR-EX002-SYN; SSN (made up) 000-02-6713 |
| Document date | 2026-01-27 |
| Author | Ottilie Harrow-Mbeki, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Two-week follow-up of an elevated blood pressure with home readings, seen the same day in wilderness and expedition medicine. [S]
Mr. Scott returns two weeks after his pre-expedition assessment, on the day of his consultation with Dr. Nwankwo-Lund. He took two home readings morning and evening for seven days with a validated upper-arm monitor; the average of the 28 readings is 138/88 mmHg, with no single reading above 150/95. He has no headache, chest pain, breathlessness, or visual change. He stopped his pipe on his quit date a week ago and takes varenicline, with mild nausea after the morning dose. He has started to use less salt. He asked whether a diagnosis of high blood pressure would count against him in leading the sledge journeys; he was told it is common, treatable, and not in itself a reason to stop him. [S]
| Element | Detail |
|---|---|
| Home blood pressure | Seven-day average 138/88 mmHg (28 readings) |
| Symptoms | None |
| Tobacco | No pipe for a week; varenicline with mild nausea |
| Concern | Whether the diagnosis limits his role on the expedition |
| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No chest pain, palpitations, or ankle swelling |
| Neurological | Negative | No headache or visual change |
| Gastrointestinal | Positive | Mild nausea after the morning varenicline dose |
| Psychiatric | Negative | Sleeping well; no low mood; occasional vivid dreams |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Varenicline 1 mg tablet, one tablet by mouth twice a day after a one-week starter titration (0.5 mg once daily for 3 days, then twice daily for 4 days) | twice a day after titration | Oral route | 2026-01-13 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-01-27 | Body height | 173 | cm | S |
| 2026-01-27 | Body weight | 72.2 | kg | S |
| 2026-01-27 | Body mass index (BMI) [Ratio] | 24.1 | kg/m2 | S |
| 2026-01-27 | Systolic blood pressure | 140 | mm[Hg] | S |
| 2026-01-27 | Diastolic blood pressure | 88 | mm[Hg] | S |
| 2026-01-27 | Heart rate | 66 | /min | S |
| 2026-01-27 | Respiratory rate | 14 | /min | S |
| 2026-01-27 | Body temperature | 36.6 | Cel | S |
| 2026-01-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
Vital signs recorded on 2026-01-27; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 140/88, pulse 66, weight 72.2 kg |
| Cardiovascular | Regular rhythm; normal heart sounds; no murmur; no radio-femoral delay; no abdominal bruit |
| Respiratory | Clear to auscultation bilaterally |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Elevated blood pressure at a pre-expedition medical assessment, 144/90 mmHg in the office without symptoms; hypertension not yet confirmed; one week of home readings requested | resolved | confirmed | R03.0 | S — Synthetic presenting finding at the pre-expedition assessment; no blood pressure from his lifetime is known. Superseded at the second visit by the confirmed diagnosis. |
| Nicotine dependence, pipe tobacco: about 25 g a week since his early twenties; first pipe within an hour of waking; has never tried to stop | active | confirmed | F17.290 | S — Synthetic modern coding anchored to his documented tobacco use on a sledge journey; the amount and pattern are synthetic. |
| Essential hypertension, stage 1, confirmed by a one-week home blood pressure average of 138/88 mmHg; normal ECG and kidney function; low ten-year cardiovascular risk | active | confirmed | I10 | S — Synthetic modern diagnosis made at the second visit; no historical measurement exists. |
| Personal history of scurvy on a long polar sledge journey in his mid-thirties, with red gums and swollen ankles and legs, treated with fresh seal meat, and full recovery; months on preserved food again ahead | active | confirmed | Z86.39 | S — Synthetic modern coding of his documented scurvy, kept on the list because the expedition will put him at risk again. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Office blood pressure, validated technique, average of two readings (target below 130/80 mmHg) | Every visit | Completed today | 140/88 mmHg |
| Self-management | Home blood pressure monitoring to confirm the diagnosis and guide treatment | At diagnosis and when treatment changes | Completed today | Seven-day average 138/88 mmHg; confirms stage 1 hypertension |
| Examination | Weight, BMI, and cardiac auscultation | Every visit | Completed today | 72.2 kg, BMI 24.1; normal heart sounds |
| Laboratory | Basic metabolic panel: sodium, potassium, creatinine, eGFR | Baseline; 2 to 4 weeks after starting an ARB; then every 6 months on an ARB | Up to date | Baseline at intake: sodium 140, potassium 4.2 mmol/L, creatinine 0.92 mg/dL, eGFR 107; not on an ARB |
| Laboratory | Urine albumin-to-creatinine ratio | At diagnosis, then yearly | Deferred | Not done: no urine sample was given at intake, and the gap was noticed today. Ordered, to be collected before the next visit |
| Laboratory | Lipid panel and HbA1c or fasting glucose | At diagnosis, then yearly | Up to date | At intake: LDL cholesterol 122 mg/dL, HbA1c 5.3%, fasting glucose 92 mg/dL |
| Laboratory | TSH | At diagnosis, then as indicated | Up to date | 2.1 mIU/L at intake |
| Imaging | Twelve-lead ECG | At diagnosis, then as indicated | Up to date | At intake: sinus rhythm; no left ventricular hypertrophy |
| Imaging | Echocardiogram | Only for stage 2 hypertension, suspected left ventricular hypertrophy, or clinical change | Not indicated | Stage 1 hypertension with no sign of left ventricular hypertrophy |
| Examination | Fundoscopic examination | Yearly | Due | At the preventive visit |
| Survey | Ten-year cardiovascular risk estimate | At diagnosis, then yearly | Completed today | About 5% by the Pooled Cohort Equations as a smoker; below 7.5% by PREVENT; lifestyle first |
| Survey | PHQ-9 depression screen | Yearly with hypertension, and before and after a long isolated posting | Up to date | PHQ-9 3 at intake |
| Survey | GAD-7 anxiety screen | Before and after a long isolated posting | Up to date | GAD-7 4 at intake |
| Self-management | Tobacco use and cessation support (varenicline with counseling) | Every visit | Completed today | Abstinent since the quit date a week ago; mild nausea on varenicline |
| Referral | Wilderness and expedition medicine consultation | Once, before a long polar expedition | Completed today | Seen by Dr. Nwankwo-Lund today |
| Self-management | Expedition nutrition plan: energy, weight, and vitamin C | Planned before departure, then weekly in the field | Ordered | Plan made with the consultant today |
| Self-management | Frostbite and hypothermia prevention and field treatment training | Before departure | Ordered | Wilderness first aid course with cold-injury modules booked |
Goal progress:
Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (Jones DW, et al. Circulation 2025;152(11):e114-e218) (2025); CMID: Clinical Monitoring Intelligence Database, hypertension monograph (2026); Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Frostbite: 2024 Update (McIntosh SE, et al. Wilderness Environ Med 2024;35(2):183-197) (2024); Wilderness Medical Society Clinical Practice Guidelines for the Out-of-Hospital Evaluation and Treatment of Accidental Hypothermia: 2019 Update (Dow J, et al. Wilderness Environ Med 2019;30(4S):S47-S69) (2019); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021)
Follow-up: Review in four weeks with home readings and the urine test. Next scheduled visit 2026-02-24: six-week review: blood pressure on lifestyle measures, tobacco, urine albumin, dental and hearing results. [S]